保险AI科技企业暖哇科技 拟赴港上市
Zhong Guo Zheng Quan Bao·2025-09-16 15:10

Core Viewpoint - Nuanwa Insight Technology Co., Ltd., a domestic insurance AI technology company, has submitted its listing application to the Hong Kong Stock Exchange, with significant revenue dependence on ZhongAn Online [1][2]. Group 1: Company Overview - Nuanwa Technology primarily provides AI-based risk analysis solutions for insurance companies, with its solutions adopted by 90 insurance companies by the end of 2024 [1]. - The company was co-founded by Lu Min and ZhongAn Online in 2018 and has undergone multiple rounds of financing [4]. Group 2: Financial Performance - Nuanwa Technology's revenue for 2022, 2023, and 2024 is projected to be 345 million, 655 million, and 944 million yuan, respectively, with a compound annual growth rate of 65.5% [2]. - The net losses for the same years are expected to be 223 million, 240 million, and 155 million yuan, while adjusted net profits are projected to be -79.31 million, 18.51 million, and 57.5 million yuan [2]. - In the first half of 2025, the company achieved revenue of 431 million yuan, slightly up from 427 million yuan in the same period last year, with a net loss of approximately 100 million yuan [2]. Group 3: Client Dependency - A significant portion of Nuanwa Technology's revenue comes from a few major clients, with revenue from the top five clients accounting for 92.3%, 82.9%, 78.9%, and 73.6% of total revenue in 2022, 2023, 2024, and the first half of 2025, respectively [2][3]. - ZhongAn Online is the most important client, contributing 78.7%, 61.8%, 45.2%, and 49.6% of total revenue in the same periods [3]. Group 4: Market Landscape - The Chinese health insurance AI technology market is projected to grow from 23.1 billion yuan in 2024 to 65.3 billion yuan by 2029, indicating significant market growth potential and intense competition [4]. - Nuanwa Technology plans to reduce its reliance on ZhongAn Online by deepening collaborations with other insurance companies and offering innovative health insurance products and value-added health management services [3][4]. Group 5: Fundraising and Future Plans - The net proceeds from the IPO will be used to enhance R&D and technical infrastructure, improve operational efficiency, expand geographical coverage, diversify insurance offerings, and for potential strategic investments in insurtech-related businesses [4].